Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its own brand. The company also promotes and markets specialty chemicals, as well as intermediates and active pharmaceuticals ingredients. It also exports its products. The company was founded in 1944 and is headquartered in Mumbai, India.
| Current Price | ₹43.50 |
|---|---|
| Market Cap | ₹33 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 38.3 |
| Return on Equity | 2.91% |
| Beta (1Y) | 0.18 |
1. Pharmaceutical Formulations and API Products-100%
Chanfta Bhagat Pharma Ltd is trading at ₹43.50, with a market capitalisation of ₹33 Cr.
Chanfta Bhagat Pharma Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Chanfta Bhagat Pharma Ltd has a P/E of 38.3 and a return on equity of 2.91%.